Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Cirrhosis

  Free Subscription

Articles published in Intern Med

Retrieve available abstracts of 53 articles:
HTML format

Single Articles

    June 2021
  1. KOYAMA M, Yamazaki T, Joshita S, Ito A, et al
    An Autopsy Case of Primary Biliary Cholangitis with Histological Submassive Hepatic Necrosis Caused by Acute Hepatitis E Virus Infection.
    Intern Med. 2021;60:1863-1870.
    PubMed     Abstract available

  2. HONMA Y, Shibata M, Gohda T, Matsumiya H, et al
    Rapid Progression of Liver Fibrosis Induced by Acute Liver Injury Due to Immune-related Adverse Events of Atezolizumab.
    Intern Med. 2021;60:1847-1853.
    PubMed     Abstract available

    May 2021
  3. HAMAHATA A, Mitsusada S, Iwata T, Nakajima K, et al
    A Case of Liver Cirrhosis Complicated by Spontaneous Bacterial Peritonitis Caused by the Burkholderia cepacia complex.
    Intern Med. 2021 May 14. doi: 10.2169/internalmedicine.7170.
    PubMed     Abstract available

  4. KOGAMI T, Uojima H, Ebato T, Bando Y, et al
    Cartilage-hair Hypoplasia Complicated with Liver Cirrhosis Due to Chronic Intrahepatic Cholestasis: A Case Report.
    Intern Med. 2021 May 7. doi: 10.2169/internalmedicine.7483.
    PubMed     Abstract available

    March 2021
  5. SHIGEFUKU R, Iwasa M, Yoshikawa K, Takei Y, et al
    A Rare Presentation of Intraperitoneal Ectopic Varices Rupture.
    Intern Med. 2021;60:959-960.

  6. KATO S, Sakamori R, Yamada R, Murai K, et al
    The First Case of Coil Embolization for Left Gastric Vein Aneurysm with Liver Cirrhosis: A Case Report and Review of the Literature.
    Intern Med. 2021 Mar 8. doi: 10.2169/internalmedicine.6565.
    PubMed     Abstract available

    February 2021
  7. TOTSUKA M, Honda M, Kanda T, Ishii T, et al
    Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir.
    Intern Med. 2021 Feb 1. doi: 10.2169/internalmedicine.6728.
    PubMed     Abstract available

    January 2021
  8. SAKAMORI R, Yamada R, Shinkai K, Doi A, et al
    Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis.
    Intern Med. 2021;60:745-750.
    PubMed     Abstract available

  9. FUJIWARA Y, Suzuki K, Yusa K, Eizuka M, et al
    Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
    Intern Med. 2021;60:1027-1033.
    PubMed     Abstract available

  10. YOKOKAWA T, Yoshihisa A, Misaka T, Sato T, et al
    Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy.
    Intern Med. 2021;60:201-208.
    PubMed     Abstract available

    December 2020
  11. TATSUMI R, Suii H, Yamaguchi M, Arakawa T, et al
    Efficacy of Switching from Kanamycin Sulfate to Rifaximin in Patients with Hepatic Cirrhosis.
    Intern Med. 2020 Dec 22. doi: 10.2169/internalmedicine.6039.
    PubMed     Abstract available

  12. ISHIKAWA T, Sasaki R, Nishimura T, Matsuda T, et al
    Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification.
    Intern Med. 2020 Dec 7. doi: 10.2169/internalmedicine.6267.
    PubMed     Abstract available

  13. SHIMADA M, Hirashima N, Iwase H, Saito M, et al
    Evaluation of Muscle Cramp Associated with Liver Cirrhosis with a Focus on the Liver Function and Nutritional Status.
    Intern Med. 2020 Dec 7. doi: 10.2169/internalmedicine.6231.
    PubMed     Abstract available

  14. KAWANAKA M, Nishino K, Morimoto Y, Ishii K, et al
    Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years: A Case Report.
    Intern Med. 2020 Dec 7. doi: 10.2169/internalmedicine.6118.
    PubMed     Abstract available

    October 2020
  15. NISHINO K, Kawanaka M, Suehiro M, Yoshioka N, et al
    Gastric Hyperplastic Polyps after Argon Plasma Coagulation for Gastric Antral Vascular Ectasia in Patients with Liver Cirrhosis - A Case Suggesting the "Gastrin Link Theory".
    Intern Med. 2020 Oct 28. doi: 10.2169/internalmedicine.5837.
    PubMed     Abstract available

    July 2020
  16. TANIGUCHI Y, Takahashi N, Miura M, Hirase C, et al
    The Impact of Hemodialysis and Liver Cirrhosis on the Plasma Concentrations of Tyrosine Kinase Inhibitors in a Patient with Chronic Myeloid Leukemia.
    Intern Med. 2020 Jul 7. doi: 10.2169/internalmedicine.4871.
    PubMed     Abstract available

  17. SEIKE T, Komura T, Shimizu Y, Omura H, et al
    The Serum Mac-2-binding Protein Glycosylation Isomer Dynamics in Acute Liver Injury.
    Intern Med. 2020;59:1581-1588.
    PubMed     Abstract available

    May 2020
  18. KIMURA N, Tsuchiya A, Oda C, Kimura A, et al
    Portal Vein Thrombosis Associated with Trousseau Syndrome due to Urinary Bladder Squamous Cell Carcinoma in a Liver Cirrhosis Patient.
    Intern Med. 2020 May 23. doi: 10.2169/internalmedicine.4112.
    PubMed     Abstract available

    April 2020
  19. SAKAMAKI A, Yokoyama K, Yamazaki F, Kamimura H, et al
    Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis: A Case Report.
    Intern Med. 2020 Apr 23. doi: 10.2169/internalmedicine.4593.
    PubMed     Abstract available

  20. MIZUNO Y, Ishikawa T, Ishida J, Kobayashi A, et al
    The Molar Ratio of Total Branched-chain Amino Acids to Tyrosine Predicts a Digit Symbol Test Abnormality in Cirrhotic Patients.
    Intern Med. 2020 Apr 16. doi: 10.2169/internalmedicine.4298.
    PubMed     Abstract available

  21. HARAGUCHI M, Hirai S, Nakamura Y, Otsuka T, et al
    Intractable Hepatic Encephalopathy with a Large Portosystemic Shunt Successfully Treated Using Shunt-preserving Disconnection of the Portal and Systemic Circulation.
    Intern Med. 2020;59:1047-1051.
    PubMed     Abstract available

  22. SAWADA K, Takai A, Yamada T, Araki O, et al
    Hepatitis-associated Aplastic Anemia with Rapid Progression of Liver Fibrosis Due to Repeated Hepatitis.
    Intern Med. 2020;59:1035-1040.
    PubMed     Abstract available

    February 2020
  23. AKUTA N, Kawamura Y, Fujiyama S, Sezaki H, et al
    Predictors of Insulin Secretion in Japanese Patients with Histopathologically-confirmed Non-alcoholic Fatty Liver Disease.
    Intern Med. 2020;59:329-338.
    PubMed     Abstract available

    January 2020
  24. SEKO Y, Moriguchi M, Takahashi A, Okishio S, et al
    The Association between the Platelet Count and Liver Volume in Compensated Cirrhosis Patients after the Eradication of Hepatitis C virus by Direct-acting Antivirals.
    Intern Med. 2020;59:1811-1817.
    PubMed     Abstract available

  25. YOKOYAMA K, Tsuchiya N, Yamauchi R, Miyayama T, et al
    Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension.
    Intern Med. 2020;59:2089-2094.
    PubMed     Abstract available

  26. ISHIKAWA T, Endo S, Imai M, Azumi M, et al
    Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy.
    Intern Med. 2020;59:2465-2469.
    PubMed     Abstract available

    July 2019
  27. IWASA M, Ishihara T, Kato M, Isoai A, et al
    Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan.
    Intern Med. 2019 Jul 10. doi: 10.2169/internalmedicine.3091.
    PubMed     Abstract available

    February 2019
  28. NAGAYAMA I, Masuda T, Nakagawa S, Murakami T, et al
    Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease.
    Intern Med. 2019 Feb 1. doi: 10.2169/internalmedicine.2174.
    PubMed     Abstract available

    January 2019
  29. SATO T, Endo K, Kakisaka K, Suzuki Y, et al
    Decreased Mean Kurtosis in the Putamen is a Diagnostic Feature of Minimal Hepatic Encephalopathy in Patients with Cirrhosis.
    Intern Med. 2019 Jan 10. doi: 10.2169/internalmedicine.2116.
    PubMed     Abstract available

    December 2018
  30. YANG J, Lun Y, Shuai X, Liu T, et al
    Late-onset Hemochromatosis: Co-inheritance of beta-thalassemia and Hereditary Hemochromatosis in a Chinese Family: A Case Report and Epidemiological Analysis of Diverse Populations.
    Intern Med. 2018;57:3433-3438.
    PubMed     Abstract available

    November 2018
  31. YAMAUCHI R, Takata K, Shinagawa Y, Tanaka T, et al
    Hepatocellular Carcinoma Arising in a Non-cirrhotic Liver with Secondary Hemochromatosis.
    Intern Med. 2018 Nov 19. doi: 10.2169/internalmedicine.0973.
    PubMed     Abstract available

  32. SEIKE T, Komura T, Shimizu Y, Omura H, et al
    A Young Man with Non-alcoholic Steatohepatitis and Serum Anti-mitochondrial Antibody Positivity.
    Intern Med. 2018;57:3093-3097.
    PubMed     Abstract available

    October 2018
  33. ICHIKAWA T, Machida N, Kaneko H, Oi I, et al
    C-Reactive Protein can Predict Patients with Cirrhosis at a High Risk of Early Mortality after Acute Esophageal Variceal Bleeding.
    Intern Med. 2018 Oct 17. doi: 10.2169/internalmedicine.1447.
    PubMed     Abstract available

  34. MIYASAKA A, Yoshida Y, Yoshida T, Murakami A, et al
    The Real-world Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir for Hepatitis C Genotype 1.
    Intern Med. 2018;57:2807-2812.
    PubMed     Abstract available

    July 2018
  35. AKASHI M, Tajiri K, Wada A, Tsuneyama K, et al
    A Patient with Non-alcoholic Steatohepatitis Complicated by Multiple Myeloma.
    Intern Med. 2018;57:2013-2018.
    PubMed     Abstract available

  36. MATSUOKA S, Yamana Y, Ishii T, Kumagawa M, et al
    Portal-systemic Encephalopathy due to Complicated Spleno-renal Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration Using a Double Coaxial Balloon Catheter System and Shape-memory Coils.
    Intern Med. 2018;57:1861-1866.
    PubMed     Abstract available

    June 2018
  37. KAWANO A, Shigematsu H, Miki K, Ichiki Y, et al
    Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study.
    Intern Med. 2018;57:1533-1542.
    PubMed     Abstract available

    May 2018
  38. KAMIO T, Hiraoka E, Obunai K, Watanabe H, et al
    Constrictive Pericarditis as a Long-term Undetermined Etiology of Ascites and Edema.
    Intern Med. 2018;57:1487-1491.
    PubMed     Abstract available

    April 2018
  39. KASUGA K, Sako M, Kasai S, Yoshimoto H, et al
    A Case of Rat Bite Fever Caused by Streptobacillus moniliformis in a Cirrhotic Patient Initially Presenting with Various Systemic Features Resembling Henoch-Schonlein Purpura.
    Intern Med. 2018 Apr 27. doi: 10.2169/internalmedicine.9856.
    PubMed     Abstract available

  40. KONISHI H, Fukuzawa K, Mori S, Satomi-Kobayashi S, et al
    Anti-mitochondrial M2 Antibodies and Myopathy: Author's Reply.
    Intern Med. 2018;57:1189.

    March 2018
  41. HAYASHI M, Abe K, Fujita M, Okai K, et al
    Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
    Intern Med. 2018 Mar 30. doi: 10.2169/internalmedicine.0629.
    PubMed     Abstract available

  42. KITAGAWA S, Oku D, Okamura K
    Spontaneous Mesenteric-gonadal Shunt in a Patient without Cirrhosis.
    Intern Med. 2018 Mar 9. doi: 10.2169/internalmedicine.0599.

    December 2017
  43. IKARASHI Y, Kodama K, Taniai M, Hashimoto E, et al
    The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus.
    Intern Med. 2017 Dec 21. doi: 10.2169/internalmedicine.9853.
    PubMed     Abstract available

  44. UOJIMA H, Murakami S, Nakatani S, Hidaka H, et al
    Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis.
    Intern Med. 2017 Dec 8. doi: 10.2169/internalmedicine.9671.
    PubMed     Abstract available

  45. NAKATANI R, Murata T, Usui T, Moriyoshi K, et al
    Importance of the Average Glucose Level and Estimated Glycated Hemoglobin in a Diabetic Patient with Hereditary Hemolytic Anemia and Liver Cirrhosis.
    Intern Med. 2017 Dec 8. doi: 10.2169/internalmedicine.9135.
    PubMed     Abstract available

    November 2017
  46. KOMURA T, Ohta H, Seike T, Shimizu Y, et al
    The Efficacy of Corticosteroid Therapy in a Patient with Nonalcoholic Steatohepatitis Overlapping Autoimmune Hepatitis: A Case Report.
    Intern Med. 2017 Nov 20. doi: 10.2169/internalmedicine.8887.
    PubMed     Abstract available

    September 2017
  47. KOGISO T, Kobayashi M, Yamamoto K, Ikarashi Y, et al
    The Outcome of Cirrhotic Patients with Ascites is Improved by the Normalization of the Serum Sodium Level by Tolvaptan.
    Intern Med. 2017 Sep 25. doi: 10.2169/internalmedicine.9033.
    PubMed     Abstract available

    August 2017
  48. HARADA M, Yoneda A, Haruyama S, Yabuki K, et al
    Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma.
    Intern Med. 2017 Aug 21. doi: 10.2169/internalmedicine.8703.
    PubMed     Abstract available

    January 2017
  49. CHISHIMA S, Kogiso T, Matsushita N, Hashimoto E, et al
    The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
    Intern Med. 2017;56:473-480.
    PubMed     Abstract available

    January 2016
  50. IWAMOTO T, Maeda M, Hisanaga T, Saeki I, et al
    Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis.
    Intern Med. 2016;55:2911-2916.
    PubMed     Abstract available

  51. TAKUMA Y, Fukada Y, Iwadou S, Miyatake H, et al
    Surgical Resection for Hepatocellular Carcinoma with Cardiac Cirrhosis after the Fontan Procedure.
    Intern Med. 2016;55:3265-3272.
    PubMed     Abstract available

  52. HAGIWARA S, Nishida N, Chishina H, Ida H, et al
    Cases with Refractory Ascites and a Delayed Response to Tolvaptan.
    Intern Med. 2016;55:3273-3277.
    PubMed     Abstract available

  53. KOGISO T, Hashimoto E, Ito T, Hara T, et al
    Successful Treatment of Ascites using a Denver(R) Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome.
    Intern Med. 2016;55:2957-2963.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.